Increased expression of antigen presentation and coinhibitory molecules PD-L1 and PD-L2 by DLBCL-FRCs inhibited antitumor CD8+ cytolytic function in an antigen-dependent manner. The gene discussed is CD274; the disease is diffuse large B-cell lymphoma.